Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies

Shallis, R. M., Bewersdorf, J. P., Swoboda, D. M., Wei, W., Gowda, L., Prebet, T., … Zeidan, A. M. (2021, May 1). Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies. Clinical Lymphoma, Myeloma and Leukemia. Elsevier Inc. https://doi.org/10.1016/j.clml.2021.01.003